Kura Oncology, Inc. (KURA)
9.91
+0.01
(+0.10%)
USD |
NASDAQ |
Oct 28, 09:58
Kura Oncology Price : 9.91 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 9.66 | 9.90 | 9.535 | 9.90 | 1.710M |
| Oct 26, 2026 | 9.73 | 9.84 | 9.555 | 9.62 | 865013.0 |
| Oct 23, 2026 | 9.80 | 9.84 | 9.283 | 9.61 | 1.565M |
| Oct 22, 2026 | 9.85 | 10.02 | 9.72 | 9.86 | 1.062M |
| Oct 21, 2026 | 10.04 | 10.18 | 9.845 | 9.88 | 1.155M |
| Oct 20, 2026 | 9.45 | 10.28 | 9.28 | 9.98 | 1.544M |
| Oct 19, 2026 | 9.17 | 9.38 | 8.928 | 9.36 | 2.159M |
| Oct 16, 2026 | 9.68 | 9.68 | 9.05 | 9.08 | 1.783M |
| Oct 15, 2026 | 9.825 | 9.90 | 9.60 | 9.70 | 1.677M |
| Oct 14, 2026 | 9.70 | 9.86 | 9.57 | 9.61 | 1.826M |
| Oct 13, 2026 | 10.29 | 10.29 | 9.76 | 9.83 | 2.714M |
| Oct 12, 2026 | 10.60 | 10.68 | 10.31 | 10.40 | 1.213M |
| Oct 09, 2026 | 10.52 | 10.68 | 10.38 | 10.60 | 1.474M |
| Oct 08, 2026 | 10.52 | 10.55 | 10.16 | 10.52 | 1.645M |
| Oct 07, 2026 | 10.43 | 10.99 | 10.32 | 10.67 | 1.099M |
| Oct 06, 2026 | 10.75 | 10.88 | 10.34 | 10.53 | 1.310M |
| Oct 05, 2026 | 10.73 | 10.80 | 10.29 | 10.62 | 1.295M |
| Oct 02, 2026 | 10.85 | 10.97 | 10.59 | 10.65 | 1.887M |
| Oct 01, 2026 | 11.10 | 11.12 | 10.59 | 10.65 | 2.431M |
| Sep 30, 2026 | 10.90 | 10.95 | 10.60 | 10.71 | 1.871M |
| Sep 29, 2026 | 10.65 | 10.90 | 10.54 | 10.80 | 1.890M |
| Sep 28, 2026 | 10.71 | 10.83 | 10.36 | 10.61 | 1.646M |
| Sep 25, 2026 | 10.88 | 10.96 | 10.75 | 10.76 | 1.227M |
| Sep 24, 2026 | 11.00 | 11.08 | 10.66 | 10.86 | 1.772M |
| Sep 23, 2026 | 11.73 | 11.81 | 10.82 | 11.04 | 2.772M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.9386 |
| Fortress Biotech, Inc. | 1.935 |
| Spero Therapeutics, Inc. | 1.14 |
| Gossamer Bio, Inc. | 9.755 |
| ACADIA Pharmaceuticals, Inc. | 20.18 |
Price Related Metrics
| PS Ratio | 11.33 |
| PEG Ratio | -0.0603 |
| Price to Book Value | 18.20 |
| Earnings Yield | -33.93% |
| Market Cap | 881.53M |
| PEGY Ratio | -0.0603 |